CHANGJIANG PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.27 CNY | +7.56% |
|
+16.67% | -44.83% |
| Sales 2021 | 2.36B 326M 26.02B | Sales 2022 | 1.62B 223M 17.8B | Capitalization | 3.42B 472M 37.63B |
|---|---|---|---|---|---|
| Net income 2021 | 49M 6.77M 540M | Net income 2022 | -23M -3.18M -253M | EV / Sales 2021 | 2.61 x |
| Net Debt 2021 | 843M 116M 9.29B | Net Debt 2022 | 1B 138M 11.04B | EV / Sales 2022 | 2.73 x |
| P/E ratio 2021 |
108
x | P/E ratio 2022 |
-147
x | Employees | 613 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 66.46% |
More Fundamentals
* Assessed data
More news
| 1 day | +7.56% | ||
| 1 week | +16.67% | ||
| Current month | -15.78% | ||
| 1 month | -15.78% | ||
| 3 months | -33.59% | ||
| 6 months | -34.41% | ||
| Current year | -44.83% |
1 week
3.83
4.27
1 month
3.415.27
Current year
2.767.97
1 year
2.768.96
3 years
2.7624.00
5 years
2.7624.00
10 years
2.7629.01
| Managers | Title | Age | Since |
|---|---|---|---|
Lu Hong Ning
BRD | Director/Board Member | 53 | 10/07/22 |
Yue Xiao Yang
PRN | Corporate Officer/Principal | 44 | 30/04/15 |
Jin Hui Sun
PRN | Corporate Officer/Principal | 61 | 28/10/15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lu Hong Ning
BRD | Director/Board Member | 53 | 10/07/22 |
Jin Hui Sun
PRN | Corporate Officer/Principal | 61 | 28/10/15 |
Yong Xu
BRD | Director/Board Member | 45 | 28/03/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 4.27 | +7.56% | 12,234,930 |
| 26/04/24 | 3.97 | -4.57% | 12,931,300 |
| 25/04/24 | 4.16 | +2.97% | 6,447,250 |
| 24/04/24 | 4.04 | +4.94% | 6,906,346 |
| 23/04/24 | 3.85 | +5.19% | 8,536,200 |
End-of-day quote Shenzhen S.E., April 28, 2024
More quotes
Changjiang Pharmaceutical Group Co Ltd, formerly Kangyue Technology Co Ltd, is a China-based company principally engaged in the research and development, production and sales of drugs. The Company is engaged in three businesses. The pharmaceutical business is engaged in traditional Chinese medicine decoction pieces business, medicinal capsule business and pharmaceutical wholesale business. The internal combustion engine parts business is engaged in the research and development, production and sales of turbocharger products. The photovoltaic equipment business is engaged in the research and development, production and sales of photovoltaic equipment such as laminator and stitch welding machine.
Sector
Pharmaceuticals
Calendar
29/04/2024
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -44.83% | 207M | |
| +26.47% | 664B | |
| +28.13% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +14.00% | 234B | |
| +4.89% | 199B | |
| -10.06% | 196B | |
| -4.04% | 148B |
- Stock Market
- Equities
- 300391 Stock
